Ivabradine reduces cardiovascular death and hospitalization for worsening heart failure in heart failure patients

with or without
COPD2
with or without
low blood pressure5
with or without
renal dysfunction1
with severe or less
severe chronic heart
failure4
with or without
LBBB3
with or without
diabetes6

  1. Voors AA, et al. Eur J Heart Fail. 2014;16(4):426-434.
  2. Tavazzi L, et al. Int J Cardiol. 2013;170(2):182-188.
  3. Reil JC, et al. Eur J Heart Fail. 2013;15(9):1044-1052.
  4. Borer JS, et al. Am J Cardiol. 2014;113(3):497-503.
  5. Komajda M et al. Eur J Heart Fail. 2014;16(7):810-816.
  6. Swedberg K, et al. Lancet. 2010;376(9744):875-885.